Mechanistically, ketoconazole and melatonin target PINK1-Parkin-mediated mitophagy to induce apoptosis, sensitizing HCC cells to sorafenib treatment [25, 97] (Fig. 7B). The gene discussed is PINK1; the disease is hepatocellular carcinoma.